SMNR (Semnur Pharmaceuticals) General and Admin. Expense: $160.70 Mil (TTM As of Mar. 2026)


SMNR Semnur Pharmaceuticals Inc SMNR
8 GF Score
Price $0.65
View Full Analysis

What is Semnur Pharmaceuticals General and Admin. Expense?

Semnur Pharmaceuticals SMNR 8 General and Admin. Expense is $160.70 Mil as of Mar. 2026. GuruFocus rates SMNR with a GF Score™ of 8/100.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Semnur Pharmaceuticals's General and Admin. Expense for the three months ended in Mar. 2026 was $3.31 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 was $160.70 Mil.

Semnur Pharmaceuticals General and Admin. Expense Related Terms

Semnur Pharmaceuticals General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Semnur Pharmaceuticals's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Semnur Pharmaceuticals General and Admin. Expense Chart

Semnur Pharmaceuticals Annual Data
Trend Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
1.65 1.64 2.98 157.87

Semnur Pharmaceuticals Quarterly Data
Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.48 0.50 151.45 5.44 3.31
SMNR
8GF Score
Semnur Pharmaceuticals Inc SMNR
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Semnur Pharmaceuticals General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $160.70 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of $160.70 Mil mean?
Semnur Pharmaceuticals (SMNR) has a General and Admin. Expense of $160.70 Mil as of Mar. 2026. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Semnur Pharmaceuticals and its competitors.
Is Semnur Pharmaceuticals' General and Admin. Expense too high?
Semnur Pharmaceuticals' current General and Admin. Expense is $160.70 Mil. Overall, Semnur Pharmaceuticals has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Semnur Pharmaceuticals' General and Admin. Expense compare to CNTB and ENLV?
Semnur Pharmaceuticals' General and Admin. Expense of $160.70 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Biotechnology company?
A good General and Admin. Expense depends on the Biotechnology industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Semnur Pharmaceuticals and its competitors. Semnur Pharmaceuticals's current General and Admin. Expense is $160.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Semnur Pharmaceuticals stock overvalued right now?
Semnur Pharmaceuticals (SMNR) has a current General and Admin. Expense of $160.70 Mil. The current General and Admin. Expense is $160.70 Mil. Semnur Pharmaceuticals' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Semnur Pharmaceuticals (SMNR), the current General and Admin. Expense is $160.70 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Semnur Pharmaceuticals Business Description

Address 960 San Antonio Road, Palo Alto, CA, USA, 94303
Semnur Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its main product candidate, SP-102 (10 mg, dexamethasone sodium phosphate viscous gel), is being developed as a non-opioid novel injectable corticosteroid gel formulation for patients with moderate to severe LRP (also known as sciatica), containing no preservatives, surfactants, solvents, or particulates.
8GF Score

Get the complete analysis for SMNR

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.65
Price